CME: Early Diagnosis/Long-Term Prognosis of MS - Dr. Jiwon Oh - Prova Education

ReachMD Healthcare Image

Media formats available:

Details

Overview
While at ECTRIMS 2015, we sat down with Dr. Jiwon Oh to discuss new insights into early diagnosis of MS and assessing a patient’s long-term prognosis.
Publication Dates
Release Date: 12/14/2015

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Treatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics
Treatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics
CME/CE
Treatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics
0.75 credits
- Vera Bril, MD
- Neelam Goyal, MD
0.75 credits
A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
MinuteCE®
A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
1.00 program credit
- Vera Bril, MD
- Nicholas J. Silvestri, MD
1.00 program credit
Ocular to Generalized MG: How and Why the Disease Evolves
Ocular to Generalized MG: How and Why the Disease Evolves
MinuteCE®
Ocular to Generalized MG: How and Why the Disease Evolves
1.00 program credit
- Vera Bril, MD
- Hans Katzberg, MD
1.00 program credit
Treatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection
Treatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection
CME/CE
Treatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection
0.75 credits
- Vera Bril, MD
- Jonathan Strober, MD
0.75 credits